IDT acquires next-gen research assays from Invitae Corporation – Corridor Business Journal

… panels — and bioinformatics, Archer’s Boulder, Colorado facility and licensed rights to Invitae’s Anchored Multiplex PCR (AMP) technology.

• Continue
• Vote Up +0 Vote Down -0You already voted!
• Read More